Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 19, 2015 10:36 AM ET


Company Overview of VentiRx Pharmaceuticals, Inc.

Executive Profile

Atul Saran

Senior Vice President and General Counsel, MacroGenics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Atul Saran has been Senior Vice President and General Counsel at MacroGenics, Inc. since April 30, 2014. Prior to joining MacroGenics, Mr. Saran spent over a decade at AstraZeneca and MedImmune. Mr. Saran served as the Vice President of Corporate Development & Ventures for AstraZeneca PLC, a multinational pharmaceutical and biologics company since May 2013. Mr. Saran served as Senior Vice President of Corporate Development and Ventures at MedImmune Ventures, Inc. ...

Corporate Headquarters

1191 Second Avenue
Seattle, Washington 98101

United States

Phone: 206-689-2259
Fax: 206-973-1588

Board Members Memberships

Former Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee


Stanford University
University of Illinois College of Law

Other Affiliations

Annual Compensation

Total Annual Compensation$228,867

Stocks Options

Restricted Stock Awards$469,575
All Other Compensation$53,900
Exercisable Options$11,250
Unexercisable Options$108,250
Total Number of Options$119,500

Total Compensation

Total Annual Cash Compensation$370,767
Total Short Term Compensation$228,867
Other Long Term Compensation$523,475
Total Calculated Compensation$2,572,836

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VentiRx Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at